 |
Molika Ashford is a GenomeWeb contributing editor and covers personalized medicine and molecular diagnostics. E-mail Molika Ashford. |
FDA Clinical PGx Guidance Pushes Early Consideration of Genomic Data in Drug Research
January 30, 2013
FDA Clinical PGx Guidance Pushes Early Consideration of Genomic Data in Drug Research
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- GenomeWeb Feature: The Rise of Lung Cancer Genetic Testing
May 8, 2013 / Pharmacogenomics Reporter - Mayo Study Highlights How Concurrent NSCLC Mutations May Complicate Genetic Testing Strategies
April 24, 2013 / Pharmacogenomics Reporter - Prostate Cancer Risk Markers Show Promise for Test to ID Elevated Risk in Men with Benign Hyperplasia
April 3, 2013 / Pharmacogenomics Reporter - At AGBT, FDA Official Says Agency Will Regulate NGS-based Tests, Stressing 'Nothing is Finalized'
February 27, 2013 / Clinical Sequencing News - Atossa Warned by FDA Over its MASCT Platform
February 25, 2013 / GenomeWeb Daily News